TAK logo

TAK Cost of Revenue

Latest reported¥1.91T JPY
TAK TTM Cost of Revenue · JPY (¥282.90B → ¥1.91T)
High-resolution chart · PNG

TAK cost of revenue history

Trailing twelve months (TTM) · JPY. Each value covers four complete reported quarters.

Takeda Pharmaceutical Company Limited American Depositary Shares (each representing 1/2 of a share of Common Stock) Cost of Revenue — Trailing twelve months (TTM) (JPY)
Period endingCost of Revenue (JPY)
1,910,441,466,000
1,888,440,466,000
1,699,701,714,000
1,563,710,000,000
1,577,960,000,000
1,580,239,000,000
1,585,467,000,000
1,548,074,000,000
1,497,345,000,000
1,431,505,000,000
1,353,949,000,000
1,310,441,000,000
1,272,304,000,000
1,244,072,000,000
1,242,680,000,000
1,188,111,000,000
1,158,463,000,000
1,106,845,000,000
1,051,911,000,000
1,023,649,000,000
997,494,000,000
994,308,000,000
989,043,000,000
1,015,476,000,000
1,037,544,000,000
1,100,058,000,000
1,141,712,000,000
1,000,651,000,000
839,692,000,000
659,690,000,000
480,747,000,000
484,520,000,000
495,642,000,000
495,920,000,000
519,435,000,000
524,638,000,000
544,227,000,000
558,754,000,000
557,312,000,000
554,848,000,000
549,679,000,000
535,405,000,000
537,023,000,000
531,417,000,000
524,072,000,000
520,990,000,000
517,350,000,000
509,467,000,000
500,656,000,000
497,708,000,000
477,837,000,000
466,796,000,000
459,406,000,000
447,628,000,000
464,731,000,000
489,689,000,000
457,607,000,000
433,194,000,000
387,906,000,000
326,564,000,000
323,380,000,000
317,582,000,000
305,130,000,000
295,266,000,000
286,831,000,000
285,065,000,000
282,903,000,000
279,217,000,000
282,252,000,000
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.